| scholarly article | Q13442814 |
| P50 | author | Jeanelle Sheeder | Q37830715 |
| Philip Zeitler | Q42171359 | ||
| P2093 | author name string | Kathy Love-Osborne | |
| P2860 | cites work | Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program | Q34451051 |
| Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children | Q34997528 | ||
| Goal setting as a strategy for dietary and physical activity behavior change: a review of the literature | Q35960555 | ||
| The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance | Q37240093 | ||
| Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention | Q40508246 | ||
| The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward? | Q40553813 | ||
| The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes | Q43596715 | ||
| Beneficial effects of metformin in normoglycemic morbidly obese adolescents | Q43816735 | ||
| Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial | Q44486255 | ||
| Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. | Q46943053 | ||
| Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus. | Q51605393 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| insulin resistance | Q1053470 | ||
| teenager | Q1492760 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 817-822 | |
| P577 | publication date | 2008-03-19 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Addition of metformin to a lifestyle modification program in adolescents with insulin resistance | |
| P478 | volume | 152 |
| Q37553110 | A longitudinal study of serum insulin and insulin resistance as predictors of weight and body fat gain in African American and Caucasian children |
| Q39816708 | A randomized, triple masked, placebo-controlled clinical trial for controlling childhood obesity. |
| Q34557477 | AMPK as Target for Intervention in Childhood and Adolescent Obesity |
| Q38886919 | An Integrative Analysis of the Effect of Lifestyle and Pharmacological Interventions on Glucose Metabolism in the Prevention and Treatment of Youth-Onset Type 2 Diabetes |
| Q35825708 | Appetite regulation and weight control: the role of gut hormones |
| Q37942290 | Assessment and management of obesity in childhood and adolescence |
| Q36099847 | Assessment of metformin as an additional treatment to therapeutic lifestyle changes in pediatric patients with metabolic syndrome |
| Q44060809 | Carbohydrate metabolism disorders among obese children and adolescents. Diabetes mellitus type 2 |
| Q28279770 | Drug interventions for the treatment of obesity in children and adolescents |
| Q36999950 | Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance |
| Q36979445 | Effects of a Comprehensive, Intensive Lifestyle Intervention Combined with Metformin Extended Release in Obese Adolescents. |
| Q33647988 | Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients |
| Q34527061 | Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial |
| Q38056388 | Efficacy and safety of metformin for treatment of overweight and obesity in adolescents: an updated systematic review and meta-analysis. |
| Q90236640 | Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review |
| Q37106506 | Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial |
| Q35413700 | Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy |
| Q33893011 | Identification and treatment of metabolic complications in pediatric obesity |
| Q43243485 | Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? |
| Q35620224 | Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes |
| Q41085122 | Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial |
| Q33740123 | METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents - study protocol of a randomized controlled study |
| Q34620649 | Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy |
| Q37794302 | Managing childhood obesity: when lifestyle change is not enough |
| Q38051221 | Metabolic syndrome in youth: chimera or useful concept? |
| Q36402111 | Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up |
| Q37319254 | Metformin for obesity in children and adolescents: a systematic review |
| Q44667403 | Metformin for overweight women at midlife: a double-blind, randomized, controlled trial. |
| Q46039889 | Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance. |
| Q50474740 | Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes. |
| Q36403722 | Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults |
| Q30413605 | Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat. |
| Q57176979 | New Insights about How to Make an Intervention in Children and Adolescents with Metabolic Syndrome: Diet, Exercise vs. Changes in Body Composition. A Systematic Review of RCT |
| Q47692391 | Novel Insights in the Metabolic Syndrome in Childhood and Adolescence |
| Q45157488 | Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents |
| Q47762246 | Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. |
| Q38817489 | Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations. |
| Q38264661 | Pharmacological management of obesity in pediatric patients |
| Q37801370 | Pharmacological treatment of obesity in children and adolescents: current status and perspectives. |
| Q37694532 | Pharmacotherapy and weight-loss supplements for treatment of paediatric obesity. |
| Q37581447 | Pharmacotherapy in pediatric obesity: current agents and future directions |
| Q37817710 | Physical activity as the main therapeutic tool for metabolic syndrome in childhood |
| Q92435004 | Precision medicine in adult and pediatric obesity: a clinical perspective |
| Q36485989 | Predictors of weight-loss response with glucagon-like peptide-1 receptor agonist treatment among adolescents with severe obesity |
| Q33798608 | Preteen insulin levels interact with caloric intake to predict increases in obesity at ages 18 to 19 years: a 10-year prospective study of black and white girls |
| Q37428359 | RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models |
| Q44981325 | Race, childhood insulin, childhood caloric intake, and class 3 obesity at age 24: 14-year prospective study of schoolgirls. |
| Q33749648 | Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome |
| Q90236672 | Role of metformin in overweight and obese people without diabetes: a systematic review and network meta-analysis |
| Q35493180 | Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. |
| Q47393234 | The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents |
| Q43257763 | Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin |
| Q41777831 | Treatment of obesity in children and adolescents |
| Q35110509 | Unplanned medication discontinuation as a potential pharmacovigilance signal: a nested young person cohort study |
| Q37848915 | Use of metformin in pediatric age. |
Search more.